Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages
- PMID: 7730221
- DOI: 10.1093/jac/34.6.1051
Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages
Abstract
Cryptococcus neoformans is responsible for pulmonary and meningal infections in HIV patients. The lack of effective cellular cooperation caused by the low level of CD4+ cells, and the resistance of C. neoformans to phagocytosis allows growth and persistence of the yeast in the host. We describe here an in-vitro model of intracellular replication of C. neoformans inside J774-A.1 macrophages, and the determination of the intracellular antifungal activity of amphotericin B and fluconazole alone or in association with IFN-gamma. The maximum inhibitory effect was observed with one MIC of amphotericin B and 100 or 1000 IU/mL of IFN-gamma. amphotericin B alone (at 1 x MIC), or either 1 x or 50 x MIC of fluconazole in normal or IFN-gamma activated macrophages, did not eradicate the ingested yeast. A potential underlying mechanism of the synergy of amphotericin B in IFN-gamma primed macrophages was investigated by measurement of nitrite level and by use of the NO synthase competitive inhibitor, NG-monomethyl L-arginine (NMMA). One MIC of amphotericin B was able to activate the synthesis of nitrogen reactive intermediates in IFN gamma-primed macrophages. NMMA treated infected macrophages responded less well to IFN-gamma priming, resulting in a moderate inhibition in subsequent amphotericin B exposure.
Similar articles
-
Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.Antimicrob Agents Chemother. 1997 Aug;41(8):1825-9. doi: 10.1128/AAC.41.8.1825. Antimicrob Agents Chemother. 1997. PMID: 9257771 Free PMC article.
-
Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.PLoS One. 2019 Dec 4;14(12):e0225701. doi: 10.1371/journal.pone.0225701. eCollection 2019. PLoS One. 2019. PMID: 31800598 Free PMC article.
-
Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.Diagn Microbiol Infect Dis. 2005 Jan;51(1):19-29. doi: 10.1016/j.diagmicrobio.2004.08.013. Diagn Microbiol Infect Dis. 2005. PMID: 15629225
-
Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.Antimicrob Agents Chemother. 1996 Aug;40(8):1919-23. doi: 10.1128/AAC.40.8.1919. Antimicrob Agents Chemother. 1996. PMID: 8843304 Free PMC article.
-
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.J Mycol Med. 2012 Sep;22(3):243-8. doi: 10.1016/j.mycmed.2012.06.002. Epub 2012 Aug 10. J Mycol Med. 2012. PMID: 23518082
Cited by
-
Benzothiourea Derivatives Target the Secretory Pathway of the Human Fungal Pathogen Cryptococcus neoformans.ACS Infect Dis. 2020 Mar 13;6(3):529-539. doi: 10.1021/acsinfecdis.9b00478. Epub 2020 Feb 26. ACS Infect Dis. 2020. PMID: 32070095 Free PMC article.
-
Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifen.PLoS One. 2015 May 27;10(5):e0125927. doi: 10.1371/journal.pone.0125927. eCollection 2015. PLoS One. 2015. PMID: 26016941 Free PMC article.
-
Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.mBio. 2014 Feb 11;5(1):e00765-13. doi: 10.1128/mBio.00765-13. mBio. 2014. PMID: 24520056 Free PMC article.
-
A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis.Eukaryot Cell. 2013 Feb;12(2):278-87. doi: 10.1128/EC.00314-12. Epub 2012 Dec 14. Eukaryot Cell. 2013. PMID: 23243064 Free PMC article.
-
Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.Antimicrob Agents Chemother. 2010 May;54(5):1785-92. doi: 10.1128/AAC.01513-09. Epub 2010 Feb 22. Antimicrob Agents Chemother. 2010. PMID: 20176901 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials